Review

Multiple system atrophy: cellular and molecular pathology

D J Burn¹, E Jaros²

¹ Regional Neurosciences Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
² Institute for the Health of the Elderly, Department of Neuropathology, Newcastle General Hospital

Correspondence to:
Dr Burn d.j.burn{at}ncl.ac.uk

Multiple system atrophy is an adult onset neurodegenerative disease, featuring parkinsonism, ataxia, and autonomic failure, in any combination. The condition is relentlessly progressive and responds poorly to treatment. Death occurs on average six to seven years after the onset of symptoms. No familial cases of multiple system atrophy have been reported, and no environmental factors have been robustly implicated as aetiological factors. However, analytical epidemiological studies are hampered because the condition is relatively rare. The discovery of the glial cytoplasmic inclusion (GCI) in 1989 helped to define multiple system atrophy as a clinicopathological entity, and drew attention to the prominent, if not primary, role played by the oligodendrocyte in the pathogenesis of the condition. Subsequently, GCIs were shown to be positive for -synuclein, with immunostaining for this protein indicating that white matter pathology was more widespread than had previously been recognised. The presence of -synuclein in GCIs provides a link with Parkinson's disease, dementia with Lewy bodies, and neurodegeneration with brain iron accumulation, type 1 (or Hallervorden-Spatz syndrome), in which -synuclein is also found within Lewy bodies. This has led to the term "synucleinopathy" to embrace this group of conditions. The GCIs of multiple system atrophy contain a range of other cytoskeletal proteins. It is unknown how fibrillogenesis occurs, and whether there is primary oligodendrocytic dysfunction, which then disrupts the neurone/axon as a consequence of the glial pathology, or whether the oligodendrocytic changes merely represent an epiphenomenon. Further research into this devastating condition is urgently needed to improve our understanding of the pathogenesis, and also to produce new treatment approaches.

Key Words: multiple system atrophy • glial cytoplasmic inclusion • -synuclein • oligodendrocyte

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Kragh, C. L., Lund, L. B., Febbraro, F., Hansen, H. D., Gai, W.-P., El-Agnaf, O., Richter-Landsberg, C., Jensen, P. H. (2009). {alpha}-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells. J. Biol. Chem. 284: 10211-10222 [Abstract] [Full Text]  
• Shults, C. W., Rockenstein, E., Crews, L., Adame, A., Mante, M., Larrea, G., Hashimoto, M., Song, D., Iwatsubo, T., Tsuboi, K., Masliah, E. (2005). Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human {alpha}-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy. J. Neurosci. 25: 10689-10699 [Abstract] [Full Text]  
• Stefanova, N., Reindl, M., Neumann, M., Haass, C., Poewe, W., Kahle, P. J., Wenning, G. K. (2005). Oxidative Stress in Transgenic Mice with Oligodendroglial {alpha}-Synuclein Overexpression Replicates the Characteristic Neuropathology of Multiple System Atrophy. Am. J. Pathol. 166: 869-876 [Abstract] [Full Text]  
• Muzaimi, M B, Thomas, J, Palmer-Smith, S, Rosser, L, Harper, P S, Wiles, C M, Ravine, D, Robertson, N P (2004). Population based study of late onset cerebellar ataxia in south east Wales. J. Neurol. Neurosurg. Psychiatry 75: 1129-1134 [Abstract] [Full Text]  
• RECCHIA, A., DEBETTO, P., NEGRO, A., GUIDOLIN, D., SKAPER, S. D., GIUSTI, P. (2004). {alpha}-Synuclein and Parkinson's disease. FASEB J. 18: 617-626 [Abstract] [Full Text]  
• Liang, T., Spence, J., Liu, L., Strother, W. N., Chang, H. W., Ellison, J. A., Lumeng, L., Li, T.-K., Foroud, T., Carr, L. G. (2003). alpha -Synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alcohol-preferring and -nonpreferring rats. Proc. Natl. Acad. Sci. USA 100: 4690-4695 [Abstract] [Full Text]